40 related articles for article (PubMed ID: 6343768)
1. Hybridoma technology; advancements, clinical significance, and future aspects.
Mitra S; Tomar PC
J Genet Eng Biotechnol; 2021 Oct; 19(1):159. PubMed ID: 34661773
[TBL] [Abstract][Full Text] [Related]
2. Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.
Smith SA; Crowe JE
Microbiol Spectr; 2015 Feb; 3(1):AID-0027-2014. PubMed ID: 26104564
[TBL] [Abstract][Full Text] [Related]
3. Development of human monoclonal antibodies: A review.
Lindl T
Cytotechnology; 1996 Jan; 21(3):183-93. PubMed ID: 22358750
[TBL] [Abstract][Full Text] [Related]
4. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
Yu X; McGraw PA; House FS; Crowe JE
J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
[TBL] [Abstract][Full Text] [Related]
5. Human monoclonal antibodies: methods of production and some aspects of their application in oncology.
Olsson L
Med Oncol Tumor Pharmacother; 1984; 1(4):235-46. PubMed ID: 6400038
[TBL] [Abstract][Full Text] [Related]
6. Human monoclonal antibodies.
Cole SP; Campling BG; Atlaw T; Kozbor D; Roder JC
Mol Cell Biochem; 1984 Jun; 62(2):109-20. PubMed ID: 6087121
[TBL] [Abstract][Full Text] [Related]
7. Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen.
Schmidt-Ullrich R; Brown J; Whittle H; Lin PS
J Exp Med; 1986 Jan; 163(1):179-88. PubMed ID: 2416867
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies in clinical immunobiology. Derivation, potential, and limitations.
Olsson L
Allergy; 1983 Apr; 38(3):145-54. PubMed ID: 6342457
[No Abstract] [Full Text] [Related]
9. [Technics of monoclonal antibody production with hybridomas and their medical application].
Yamamoto K; Nakauchi H; Okumura K
Nihon Rinsho; 1981; 39(12):3788-95. PubMed ID: 7040735
[No Abstract] [Full Text] [Related]
10. Human--human monoclonal antibody-producing hybridomas: technical aspects.
Olsson L; Kaplan HS
Methods Enzymol; 1983; 92():3-16. PubMed ID: 6343768
[No Abstract] [Full Text] [Related]
11. Antibody producing human-human hybridomas. I. Technical aspects.
Olsson L; Kronstrøm H; Cambon-De Mouzon A; Honsik C; Brodin T; Jakobsen B
J Immunol Methods; 1983 Jun; 61(1):17-32. PubMed ID: 6343505
[TBL] [Abstract][Full Text] [Related]
12. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.
Spieker-Polet H; Sethupathi P; Yam PC; Knight KL
Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9348-52. PubMed ID: 7568130
[TBL] [Abstract][Full Text] [Related]
13. Bispecific monoclonal antibodies from hybrid hybridomas.
Suresh MR; Cuello AC; Milstein C
Methods Enzymol; 1986; 121():210-28. PubMed ID: 3724461
[No Abstract] [Full Text] [Related]
14. Use of heterohybridomas in xenotransplantation.
Yang Q; Bollinger RR; De Buysscher EV
Transplant Proc; 1992 Apr; 24(2):457-8. PubMed ID: 1566389
[No Abstract] [Full Text] [Related]
15. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
Teng NN; Lam KS; Calvo Riera F; Kaplan HS
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
